CA1333616C
(en)
*
|
1989-03-09 |
1994-12-20 |
Hector F. Deluca |
19-nor-vitamin d compounds
|
US5763428A
(en)
*
|
1990-09-21 |
1998-06-09 |
Bone Care International, Inc. |
Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
|
PL170447B1
(en)
*
|
1990-09-21 |
1996-12-31 |
Lunar Corp |
Method of obtaining novel 1 alpha-hydroxyvitamin d4 and novel transition and analog compounds
|
US5798345A
(en)
*
|
1990-09-21 |
1998-08-25 |
Bone Care International, Inc. |
Method of inhibiting the hyperproliferation of malignant cells
|
US6025346A
(en)
*
|
1990-09-21 |
2000-02-15 |
Bone Care International, Inc. |
1α-hydroxy vitamin D4 and novel intermediates and analogues
|
US5182396A
(en)
*
|
1991-03-29 |
1993-01-26 |
Nisshin Flour Milling Co., Ltd. |
1-hydroxyvitamin d derivatives
|
DE69213844T2
(de)
*
|
1991-07-05 |
1997-04-10 |
Duphar Int Res |
Vitamin-D Derivat, Verfahren zu dessen Herstellung sowie Zwischenprodukte dafür
|
DE4220757A1
(de)
*
|
1992-06-24 |
1994-01-05 |
Schering Ag |
Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
|
AU666563B2
(en)
*
|
1992-08-07 |
1996-02-15 |
Wisconsin Alumni Research Foundation |
Preparation of 19-nor-vitamin D compounds
|
TW267161B
(no)
*
|
1992-11-20 |
1996-01-01 |
Hoffmann La Roche |
|
DE69400495T2
(de)
*
|
1993-04-05 |
1997-04-30 |
Wisconsin Alumni Res Found |
19-Nor-vitamin-D3-Verbindung mit einem Substituent an die 2. Stelle
|
PT707566E
(pt)
*
|
1993-07-09 |
2000-09-29 |
Theramex |
Novos analogos estruturais da vitamina d
|
US5763429A
(en)
|
1993-09-10 |
1998-06-09 |
Bone Care International, Inc. |
Method of treating prostatic diseases using active vitamin D analogues
|
US20040043971A1
(en)
*
|
1995-04-03 |
2004-03-04 |
Bone Care International, Inc. |
Method of treating and preventing hyperparathyroidism with active vitamin D analogs
|
US6242434B1
(en)
*
|
1997-08-08 |
2001-06-05 |
Bone Care International, Inc. |
24-hydroxyvitamin D, analogs and uses thereof
|
US20020183288A1
(en)
*
|
1995-04-03 |
2002-12-05 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
US5597815A
(en)
*
|
1995-07-13 |
1997-01-28 |
Wisconsin Alumni Research Foundation |
Prevention of hyperphosphatemia in kidney disorder patients
|
US5716946A
(en)
*
|
1996-02-13 |
1998-02-10 |
Wisconsin Alumni Research Foundation |
Multiple sclerosis treatment
|
US20020128240A1
(en)
*
|
1996-12-30 |
2002-09-12 |
Bone Care International, Inc. |
Treatment of hyperproliferative diseases using active vitamin D analogues
|
US6573256B2
(en)
|
1996-12-30 |
2003-06-03 |
Bone Care International, Inc. |
Method of inhibiting angiogenesis using active vitamin D analogues
|
US6566353B2
(en)
|
1996-12-30 |
2003-05-20 |
Bone Care International, Inc. |
Method of treating malignancy associated hypercalcemia using active vitamin D analogues
|
US6503893B2
(en)
|
1996-12-30 |
2003-01-07 |
Bone Care International, Inc. |
Method of treating hyperproliferative diseases using active vitamin D analogues
|
US6929797B2
(en)
|
1997-02-13 |
2005-08-16 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
US20030129194A1
(en)
*
|
1997-02-13 |
2003-07-10 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
US5945410A
(en)
|
1997-03-17 |
1999-08-31 |
Wisconsin Alumni Research Foundation |
2-alkyl-19-nor-vitamin D compounds
|
US6316642B1
(en)
|
1997-03-17 |
2001-11-13 |
Wisconsin Alumni Research Foundation |
26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
|
US6306844B1
(en)
|
1997-03-17 |
2001-10-23 |
Wisconsin Alumni Research Foundation |
Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
|
US6392071B1
(en)
*
|
1997-03-17 |
2002-05-21 |
Wisconsin Alumni: Research Foundation |
26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
|
US5843928A
(en)
*
|
1997-03-17 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
2-alkylidene-19-nor-vitamin D compounds
|
US5939406A
(en)
|
1997-07-21 |
1999-08-17 |
Wisconsin Alumni Research Foundation |
18-substituted-19-nor-vitamin D compounds
|
US6359152B2
(en)
|
1997-07-21 |
2002-03-19 |
Wisconsin Alumni Research Foundation |
18-substituted-19-nor-vitamin D compounds
|
AU762481C
(en)
|
1998-03-27 |
2004-08-19 |
Oregon Health Sciences University |
Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
|
US5972917A
(en)
*
|
1998-05-29 |
1999-10-26 |
Bone Care Int Inc |
1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
|
IL139354A
(en)
|
1998-05-29 |
2005-08-31 |
Bone Care Internat Inc |
Method for making hydroxy-25 ene-vitamin d compounds
|
US5962707A
(en)
*
|
1998-08-18 |
1999-10-05 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D3 compounds with calcemic activity
|
US6479474B2
(en)
|
1999-07-08 |
2002-11-12 |
Wisconsin Alumni Research Foundation |
Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
|
US7122533B2
(en)
*
|
1999-11-29 |
2006-10-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cosalane compounds and methods for their use
|
US6806262B2
(en)
*
|
2000-05-31 |
2004-10-19 |
Wisconsin Alumni Research Foundation |
2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
|
WO2002005823A2
(en)
*
|
2000-07-14 |
2002-01-24 |
Wisconsin Alumni Research Foundation |
USE OF 2-METHYLENE-19-NOR-20(S)-1α,25-DIHYDROXYVITAMIN D3 TO INCREASE BONE STRENGTH
|
AU7895601A
(en)
*
|
2000-07-18 |
2002-01-30 |
Bone Care Int Inc |
Stabilized 1alpha-hydroxy vitamin d
|
MXPA03001969A
(es)
|
2000-09-08 |
2003-06-24 |
Wisconsin Alumni Res Found |
1-alfa-hidroxi-2-metilen-19-nor-homopregnacalciferol y sus aplicaciones terapeuticas.
|
JP2005504279A
(ja)
*
|
2001-09-27 |
2005-02-10 |
ザ・コカ−コーラ・カンパニー |
食品のビタミン強化
|
US6627622B2
(en)
|
2002-02-18 |
2003-09-30 |
Wisconsin Alumni Research Foundation |
(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
|
US6566352B1
(en)
|
2002-02-18 |
2003-05-20 |
Wisconsin Alumni Research Foudation |
1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
|
EP2316469A1
(en)
|
2002-02-22 |
2011-05-04 |
Shire LLC |
Delivery system and methods for protecting and administering dextroamphetamine
|
US20030195175A1
(en)
*
|
2002-03-25 |
2003-10-16 |
Deluca Hector F. |
Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
|
JP3957303B2
(ja)
*
|
2002-03-29 |
2007-08-15 |
ウィスコンシン・アルムニ・リサーチ・ファウンデーション |
1α−ヒドロキシ−2−メチレン−19−ノル−ホモプレグナカルシフェロールの合成法
|
US20040053895A1
(en)
*
|
2002-09-18 |
2004-03-18 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US20040058895A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
CA2516233C
(en)
*
|
2003-04-10 |
2011-09-20 |
Wisconsin Alumni Research Foundation |
2-propylidene-19-nor-vitamin d compounds
|
US6894037B2
(en)
*
|
2003-07-03 |
2005-05-17 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
|
US20050009792A1
(en)
*
|
2003-07-08 |
2005-01-13 |
Deluca Hector F. |
(20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses
|
US20050148557A1
(en)
*
|
2003-07-29 |
2005-07-07 |
Jin Tian |
Use of Vitamin Ds to treat kidney disease
|
WO2005051323A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Wisconsin Alumni Research Foundation |
Vitamin d analogs for obesity prevention and treatment
|
US7915242B2
(en)
*
|
2004-02-17 |
2011-03-29 |
Wisconsin Alumni Research Foundation |
Vitamin D receptor antagonists and their use in treating asthma
|
US7214671B2
(en)
*
|
2004-02-19 |
2007-05-08 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases
|
US7713951B2
(en)
*
|
2004-04-09 |
2010-05-11 |
Wisconsin Alumni Research Foundation |
2-alkylidene-18,19-dinor-vitamin D compounds
|
US20060009425A1
(en)
*
|
2004-05-28 |
2006-01-12 |
Leticia Delgado-Herrera |
Oral formulations of paricalcitol
|
US7094775B2
(en)
|
2004-06-30 |
2006-08-22 |
Bone Care International, Llc |
Method of treating breast cancer using a combination of vitamin D analogues and other agents
|
US20060003950A1
(en)
*
|
2004-06-30 |
2006-01-05 |
Bone Care International, Inc. |
Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
|
AU2005303773A1
(en)
|
2004-11-12 |
2006-05-18 |
Bioxell Spa |
Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer
|
US7244719B2
(en)
*
|
2004-11-22 |
2007-07-17 |
Wisconsin Alumni Research Foundation |
2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses
|
US9173835B2
(en)
|
2005-05-10 |
2015-11-03 |
Dermipsor Ltd. |
Compositions and methods for treating hyperproliferative epidermal diseases
|
CN101217868A
(zh)
|
2005-05-10 |
2008-07-09 |
德米普瑟尔有限公司 |
用于皮肤护理的组合物和方法
|
US20070149489A1
(en)
*
|
2005-07-18 |
2007-06-28 |
Anchel Schwartz |
Preparation of paricalcitol
|
WO2007105773A1
(ja)
|
2006-03-15 |
2007-09-20 |
Mercian Corporation |
インデン誘導体の製造方法およびその製造中間体
|
US20090281340A1
(en)
*
|
2006-04-05 |
2009-11-12 |
Deluca Hector F |
1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and treatment thereof
|
WO2007117563A2
(en)
*
|
2006-04-05 |
2007-10-18 |
Wisconsin Alumni Research Foundation |
1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
|
US20080051380A1
(en)
|
2006-08-25 |
2008-02-28 |
Auerbach Alan H |
Methods and compositions for treating cancer
|
CA2838089A1
(en)
|
2006-08-25 |
2008-02-28 |
Cougar Biotechnology, Inc. |
Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
|
US20080051375A1
(en)
*
|
2006-08-25 |
2008-02-28 |
Auerbach Alan H |
Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
|
WO2008053961A1
(fr)
|
2006-11-02 |
2008-05-08 |
Mercian Corporation |
Procédé et intermédiaire pour la fabrication du dérivé 1-hydroxy-19-norcyclovitamine d
|
CN103961686A
(zh)
*
|
2006-11-16 |
2014-08-06 |
凯制药公司 |
用于治疗甲状旁腺功能亢进和高钙血症的聚阳离子钙调节肽
|
WO2009009132A1
(en)
*
|
2007-07-12 |
2009-01-15 |
Cougar Biotechnology, Inc. |
Use of 17alpha-hydroxylase/c17, 20-lyase inhibitors for the treatment of cancer
|
US7491712B1
(en)
*
|
2007-12-10 |
2009-02-17 |
Formosa Laboratories, Inc. |
Process for preparation of paricalcitol and intermediates thereof
|
US8026379B2
(en)
*
|
2008-06-20 |
2011-09-27 |
Formosa Laboratories, Inc. |
Paricalcitol intermediates
|
WO2010009879A2
(en)
|
2008-07-22 |
2010-01-28 |
Azad Pharmaceutical Ingredients Ag |
Methods for producing paricalcitol
|
US20100075933A1
(en)
*
|
2008-07-28 |
2010-03-25 |
Sunita Vijay Shelke |
Injectable compositions of vitamin d compounds
|
CN102341110B
(zh)
|
2009-01-27 |
2017-04-12 |
博格有限责任公司 |
用于减轻与化疗有关的副作用的维生素d3及其类似物
|
AU2010278897B2
(en)
|
2009-07-29 |
2015-02-26 |
Kai Pharmaceuticals, Inc. |
Therapeutic agents for reducing parathyroid hormone levels
|
US20110033529A1
(en)
*
|
2009-08-06 |
2011-02-10 |
Durga Prasad Samantaray |
Oral pharmaceutical paricalcitol formulations
|
CN102655869B
(zh)
|
2009-08-14 |
2016-08-10 |
博格有限责任公司 |
用于治疗脱发的维生素d3及其类似物
|
US8664206B2
(en)
|
2010-03-23 |
2014-03-04 |
Wisconsin Alumni Research Foundation |
Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3
|
WO2011119622A1
(en)
*
|
2010-03-23 |
2011-09-29 |
Wisconsin Alumni Research Foundation |
DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1α,25- DIHYDROXYVITAMIN D3
|
CA2794006C
(en)
*
|
2010-03-23 |
2017-11-28 |
Wisconsin Alumni Research Foundation |
(20s)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-dihydroxyvitamin d3 and (20r)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-hydroxyvitamin d3
|
JP6059716B2
(ja)
|
2011-06-03 |
2017-01-11 |
ウイスコンシン アラムニ リサーチ ファンデーション |
(22E)−2−メチレン−26,27−シクロ−22−デヒドロ−1α−ヒドロキシ−19−ノルビタミンD3誘導体
|
EP2717896B1
(en)
|
2011-06-08 |
2016-08-24 |
Kai Pharmaceuticals, Inc. |
Therapeutic agents for regulating serum phosphorus
|
WO2013071262A1
(en)
|
2011-11-10 |
2013-05-16 |
Kai Pharmaceuticals, Inc. |
Calcimimetics and methods for their use
|
JP6608810B2
(ja)
|
2013-05-29 |
2019-11-20 |
バーグ エルエルシー |
ビタミンdを使用する化学療法誘発性脱毛症の予防又は軽減
|
EP3237377A4
(en)
*
|
2014-12-24 |
2018-08-22 |
Kyoto University |
Vitamin d3 derivatives and pharmaceutical use thereof
|
WO2017209934A1
(en)
|
2016-05-13 |
2017-12-07 |
Case Western Reserve University |
Autophagy activators for treating or preventing skin injury
|
PE20190403A1
(es)
|
2016-07-29 |
2019-03-13 |
Janssen Pharmaceutica Nv |
Metodos para tratar el cancer de prostata
|
WO2020049564A1
(en)
*
|
2018-09-06 |
2020-03-12 |
B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University |
Pharmaceutical compositions of fumaric acid esters and vitamin d derivatives and use thereof
|
US11903952B2
(en)
|
2020-05-27 |
2024-02-20 |
Northwestern University |
Vitamin D as an immune modulator to prevent immune-related complication from COVID-19 infection
|
US11932595B2
(en)
|
2020-09-17 |
2024-03-19 |
KYOTO UNIVERSITY, NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY, TEIKYO UNIVERSITY and THE UNIVERSITY OF TOKYO |
VDR-silent vitamin D derivative as inhibitors of SREBP and pharmaceutical use thereof
|